CTD small phosphatase-like protein 2 (CTDSPL2, HSPC129)是一个假设RNA-polymerase II carboxy-terminal domain (CTD)磷酸酶(1),这属于CTD磷酸酶的一个小亚家族(2)。RNA polymerase II的CTD包含多重的Y-S-P-T-S-P-S重复序列,该序列是在转录循环期间被磷酸化(3,4)。一般而言,在RNA合成的数个步骤和在转录后修饰期间,CTD磷酸酶调节RNA-polymerase II的可逆CTD磷酸化作用(4-6)。CTDSPL2蛋白有数个结构性和功能性类似与其它CTD磷酸酶,包括FCP1、SCP1、DULLARD和UBLCP1 (1,2)。
Phospho-CTDSPL2 (Ser104) Antibody detects endogenous levels of CTDSPL2 only when phosphorylated at Ser104.
Source / Purification
Polyclonal antibodies are produced by immunizing animals with a synthetic phosphopeptide corresponding to residues surrounding Ser104 of human CTDSPL2 protein. Antibodies are purified by protein A and peptide affinity chromatography.
Background
CTD small phosphatase-like protein 2 (CTDSPL2, HSPC129) is a putative RNA-polymerase II carboxy-terminal domain (CTD) phosphatase (1) that belongs to a small subfamily of CTD phosphatases (2). The CTD of RNA polymerase II contains multiple Y-S-P-T-S-P-S repeats that are phosphorylated during the transcription cycle (3,4). In general, CTD phosphatases regulate the reversible CTD phosphorylation state of RNA-polymerase II at several stages of RNA synthesis and during post-transcriptional modification (4-6). CTDSPL2 has several structural and functional similarities to other CTD phosphatases, including FCP1, SCP1, DULLARD, and UBLCP1 (1,2).
Phosphorylation of CTDSPL2 at Ser104 was identified at Cell Signaling Technology (CST) using PhosphoScan®, CST's LC-MS/MS platform for phosphorylation site discovery (7). The site was independently found in select carcinoma cell lines and in tumors (8).